Mycetoma Retrospective Data Collection

Last updated: July 31, 2024
Sponsor: Drugs for Neglected Diseases
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

A diagnosis of mycetoma in a medical, radiologic, or laboratory record.

Clinical Study ID

NCT06512714
DNDi-OBS-03-MYC
  • All Genders

Study Summary

The goal of this retrospective observational study is to describe mycetoma cases detected in health care facilities in India and Senegal in a 10-year period. The main objectives are to:

  • Determine the number of mycetoma cases diagnosed per year and trends over time.

  • Describe characteristics of diagnosed mycetoma cases.

    1. Describe demographic characteristics of patients with mycetoma.

    2. Describe clinical characteristics of patients with mycetoma upon initial presentation and over time.

  • Assess etiology of mycetoma cases.

  • Characterize clinical management of mycetoma cases.

    1. Characterize approaches to diagnosis of mycetoma.

    2. Investigate types and durations of treatments (including medical and surgical approaches) utilized to treat mycetoma cases.

    3. Describe clinical outcomes among patients with mycetoma.

The study team will review all available medical, laboratory and radiologic records of identified mycetoma cases and use data collection forms to extract relevant data.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Any patient given a diagnosis of mycetoma in a medical, radiologic, or laboratoryrecord.

Exclusion

Exclusion Criteria:

  • Patients with illegible or inaccessible health records.

Study Design

Total Participants: 1600
Treatment Group(s): 1
Primary Treatment: A diagnosis of mycetoma in a medical, radiologic, or laboratory record.
Phase:
Study Start date:
June 20, 2024
Estimated Completion Date:
August 31, 2024

Study Description

Mycetoma is a poorly understood neglected tropical disease which disproportionately affects the poorest of the poor and is associated with substantial morbidity. The disease presents a multitude of diagnostic and management challenges; in particular, effective treatments for eumycetoma, the fungal and least understood form of the disease are lacking. DNDi and partners aim to conduct late-phase clinical trials on a promising new pharmacologic treatment for eumycetoma, but substantial knowledge gaps preclude such trials. These knowledge gaps include data on the burden, distribution, causative agents, clinical presentation, natural history, and common approaches to diagnosis and treatment of mycetoma in endemic countries.

This study, a retrospective review of mycetoma cases, aims to generate such data from several countries suggested by preliminary data to potentially be good candidate clinical trial sites.

Connect with a study center

  • Postgraduate Institute of Medical Education and Research

    Chandigarh, 160012
    India

    Site Not Available

  • Universite Cheikh Anta Diop de Dakar

    Dakar,
    Senegal

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.